<PAGE>   1
FORM 10-QSB/A - QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE 
                        SECURITIES EXCHANGE ACT OF 1934

                  For the quarterly period ended March 31, 1999

                     U.S. SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC. 20549

                            Zaxis International Inc.

                  (Name of Issuer as specified in its charter)

      Delaware                    0-15476                   68-0080601
(State of Incorporation)   (Commission File Number)      (IRS Employer 
                                                       Identification No.)

                     1890 Georgetown Road, Hudson Ohio 44236
                     (Address of principal executive office)

                                  (330)650-0444
                         (Registrant's telephone number)

Check whether the registrant (1) filed all reports required to be filed by
Section 13 or 15(d) of the Exchange Act during the past 12 months and (2) has
been subject to such filings for the past 90 days. Yes[X] No []

As of March 31, 1999, there were 5,858,106 shares of Common Stock outstanding

Page 1 of 9


<PAGE>   2




                            ZAXIS INERNATIONAL. INC.
                                   FORM~1O~QSB

<TABLE>
<CAPTION>
                                                                                                   Page No.
<S>                                                                                            <C>

PART I. FINANCIAL INFORMATION

Item I  Financial Statements.
         Consolidated Balance Sheets                                                                     3

         Consolidated Statements of Operations:
                  Quarter ended March 31, 1999 and 1998                                                  4

         Consolidated Statements of Cash Flows                                                           5

           Notes to Consolidated Financial Statements                                                    6

Item 2. Management's Discussion and Analysis                                                            7-8

SIGNATURES                                                                                                9
</TABLE>


Page 2 of 9

<PAGE>   3
                     ZAXIS INTERNATIONAL INC. AND SUBSIDIARY
                           CONSOLIDATED BALANCE SHEETS
                                   UNAUDITED

                                     ASSETS
                                     ------
<TABLE>
<CAPTION>

                                                                      March 31     December 31,
                                                                        1999           1998
                                                                     -----------    -----------

Current assets:
<S>                                                                  <C>            <C>        
      Cash                                                           $    15,110    $    49,327
      Restricted cash
      Accounts receivable, net                                             8,325         13,904
      Inventory                                                           53,346         64,738
      Prepaid expenses and other                                          27,367         29,671
                                                                     -----------    -----------
                   Total current assets                                  104,148        157,640
Property and equipment:
      Machinery and equipment                                            360,730        360,082
      Office equipment                                                   190,064        190,064
      Leasehold improvements                                              86,992         86,992
                                                                         637,786        637,138
      Less accumulated depreciation                                      424,853        400,731
                                                                     -----------    -----------
                                                                         212,933        236,407
Other assets:
      Patent costs                                                        38,167         37,910
      Organization costs                                                    --              395
                                                                     -----------    -----------
                                                                          38,167         38,305
                                                                     -----------    -----------
                   Total assets                                      $   355,249    $   432,352
                                                                     ===========    ===========
                   LIABILITIES AND STOCKHOLDERS' DEFICIENCY

Current liabilities:
      Current portion of lease obligations                           $    10,906    $    10,906
      Bank loan payable
      Notes payable to directors                                         784,895        784,895
      Notes payable                                                      471,928        475,264
      Accounts payable                                                   670,774        476,962
      Accrued expenses                                                   528,856        449,341
                                                                     -----------    -----------
                   Total current liabilities                           2,467,359      2,197,368

  Long term debt:
      Capitalized lease obligations                                       26,130         28,706
      Long term notes payable                                            130,000        130,000
      Long term notes directors                                          684,012        684,012
                                                                     -----------    -----------
                   Long term debt                                        840,142        842,718

Stockholders' equity:
      Common stock                                                        58,581         58,112
        $.01 par value, 12,000,000 shares authorized,
             5,858,106 and 5,811,216 shares issued and outstanding
      Additional paid-in capital                                       5,988,092      5,984,885
      Accumulated deficit                                             (8,998,925)    (8,650,731)
                                                                     -----------    -----------
                   Total stockholders' equity                         (2,952,252)    (2,607,734)
                                                                     --------------------------
                   Total liabilities and stockholders' equity        $   355,249    $   432,352
                                                                     ===========    ===========
</TABLE>

See notes to consolidated financial statements 

Page 3 of 9


<PAGE>   4








                     ZAXIS INTERNATIONAL INC. AND SUBSIDIARY

                      CONSOLIDATED STATEMENTS OF OPERATIONS

                                   UNAUDITED
<TABLE>
<CAPTION>

                                                  THREE MONTHS ENDED
                                                        MARCH 31
                                                --------------------------
                                                   1999             1998
                                                -----------    -----------
<S>                                             <C>            <C>        
Net sales                                       $    47,948    $    49,784

Cost of goods sold                                  128,318        137,852

Selling, general and administrative expenses        218,320        171,778
                                                -----------    -----------
             Loss from operations                  (298,690)      (259,846)

Other income (expense):
  Interest income                                       150            233
  Miscellaneous income
  Loss on sale of asset
  Interest expense                                  (49,654)       (32,176)
                                                -----------    -----------
             Total other income (expense)           (49,504)       (31,943)
                                                -----------    -----------
             Net loss                           $  (348,195)   $  (291,789)
                                                ===========    ===========
Net loss per common share
              Basic                             $     (0.06)   $     (0.05)
                                                ===========    ===========
              Diluted                           $     (0.06)   $     (0.05)
                                                ===========    ===========
Weighted average number of shares outstanding
             Basic                                5,858,106      5,744,991
                                                ===========    ===========
             Diluted                              5,858,106      5,744,991
                                                ===========    ===========
</TABLE>


 See notes to consolidated financial statements.

Page 4 of 9

<PAGE>   5
                     ZAXIS INTERNATIONAL INC. AND SUBSIDIARY
                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                                    UNAUDITED


<TABLE>
<CAPTION>

                                                                   THREE MONTHS ENDED
                                                                        MARCH 31
                                                                 ----------------------
                                                                    1999        1998
                                                                 ---------    ---------
<S>                                                            <C>          <C>
OPERATING ACTIVITIES:
Net loss                                                         $(348,195)   $(291,787)
Adjustments to reconcile net loss to cash
  used in operating activities:
    Depreciation and amortization                                   26,099       29,571
    Compensation due to stock option grants                          3,676
    Changes in operating assets and liabilities:
      Accounts receivable                                            5,578       29,078
     Changes in operating assets                                     1,820
      Inventory and prepaid expenses                                11,875        2,413
      Accounts payable and accrued expenses                         81,083       45,654
                                                                 ---------    ---------

           Cash used in operating activities                      (218,064)    (185,071)

 INVESTING ACTIVITIES:
  Purchase of property and equipment                                  (648)      (6,386)
  Deposits
  Patent cost expenditures                                          (1,840)      (1,113)
                                                                 ---------    ---------

           Cash used in investing activities                        (2,488)      (7,499)

FINANCING ACTIVITIES:
  Proceeds from sales of common stock and exercise of warrants
  Net proceeds from notes payable                                  188,909      141,315
  Payments on capital lease obligations                             (2,575)      (2,217)
                                                                 ---------    ---------

           Cash provided by financing activities                   186,334      139,098
                                                                 ---------    ---------

Increase in cash                                                   (34,218)     (53,472)
Cash at beginning of period                                         49,327       81,410
                                                                 ---------    ---------

Cash at end of period                                            $  15,108    $  27,938
                                                                 =========    =========

</TABLE>


Cash at end of period variance due to rounding.


<PAGE>   6
                    ZAXIS INTERNATIONAL INC. AND SUBSIDIARY
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1.       BASIS OF PRESENTATION

The financial statements present the consolidated financial position and results
of operations of Zaxis International Inc. (International) and Zaxis Inc. (Zaxis
or the Company) its wholly-owned subsidiary.

Zaxis Incorporated was founded in 1989 as a privately held Ohio corporation. On
August 25, 1995, Zaxis merged with a subsidiary of The InFerGene Company
(InFerGene). InFerGene was an inactive publicly traded Delaware corporation
founded in 1985. Neither InFerGene nor its subsidiary had any assets or
liabilities. The merger, for accounting purposes, was a reverse acquisition in
which Zaxis acquired InFerGene. The acquisition was accounted for as a purchase
with no value assigned to InFerGene. InFerGene then changed its name to Zaxis
International Inc. The financial statements include the operations of Zaxis for
all periods presented and the operations of International since the date of
acquisition. All intercompany transactions and balances have been eliminated.

As an interim report, the financial statements and notes thereto do not include
all of the disclosures necessary for a full presentation of financial condition
and operating results, and should be read in conjunction with the financial
statements for the year ended December 31, 1998.

2.       LIQUIDITY

Zaxis incurred losses of $348,195 during the three months ended March 31, 1999,
and $291,787 in the nine months ended March 31, 1999. During 1999, operations of
the Company have been financed by loans from shareholders and private investors,
members of the Board of Directors, and related persons and entities. The Company
continues to rely upon these and related sources to sustain on-going operations,
research, product development and sales development. The Company continues with
other discussions regarding long-term debt and/or equity fundings. The Company
will continue to be reliant upon investor fundings until the marketing of the
Company's principal products can be brought to a level sufficient to support the
operating requirements of the Company. These conditions cause doubt about the
Company's ability to continue as a going concern. No adjustments to the amounts
or classification of assets and liabilities, which could result from the outcome
of this uncertainty, are reflected in the financial statements.

3.     NET LOSS PER COMMON SHARE

The effects of outstanding options and warrants have not been included in the
calculation of net less per share.



Page 6 of 9
<PAGE>   7

Item 2. Management's Discussion and Analysis.

Management's Discussion and Analysis of Financial Condition and Results of
Operations

Results of operations

Sales for the three months ended March 31, 1999, totaled $47,948 compared with
$49,784 for 1998's first three months. Cost of goods sold for the months ended
March 31, 1999, was $128,318, exceeding sales by $80,370. Cost of goods sold for
the same period in 1998, was $137,852, exceeding sales by $88,068. Selling,
general and administrative expenses were $218,320 for the three months ended
March 31, 1999, up from $171,778 for the same period in 1998.

Financial Condition and Liquidity

The Company needs to secure immediate finacing to allow it to explore several
opportunities from new products that are now available for market introduction
and to afford it time to build sales volumes of these new products to profitable
levels. In the period required for product introduction and sales growth, the
Company will need to satisfy obligations to current creditors. Pursuant to this
need, the Company continues to seek interim funding.

                           PART II. OTHER INFORMATION

Item 1.  Legal Proceedings

      None of substantial nature.

Item 2(c). Changes in Securities  None

Item 3.  Default upon Senior Securities

         The company is more than 30 days past due on principal payment on three
individual C series notes totaling $65,000. The Company is more than 30 days
past due on interest payments on above referenced C series notes and 9 1/2%
Convertible notes in the amount of $241,288.52.


Page 7 of 9


<PAGE>   8



Item 4.  Submission of  Matters to a Vote of Security Holders

None

Item 5.  Other Information

None

Item   6.  Exhibits and Reports on Form 8-K

      A. Exhibits:

         None

      B. Reports on Form 8-K during the Quarter Ended March 31, 1999:

         None

Page 8 of 9

<PAGE>   9

                                   SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused
this report to be signed on its behalf the undersigned, thereunto duly
authorized.

                                              Zaxis International Inc.
                                              ------------------------
                                                    (Registrant)

May 19, 1999                                 BY: S/S Conaly Bedell
                                                 -----------------
                                             Conaly Bedell, President
                                             Chief Executive Officer

May 19, 1999                                 BY: S/S Conaly Bedell
                                                 -----------------
                                             Acting Accounting Officer




Page 9 of 9